Ticagrelor and Cosyntropin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ticagrelor (ticagrelor) and Cosyntropin (cosyntropin). Common drug interactions include hypocalcaemia among females.

The phase IV clinical study analyzes what interactions people have when they take Ticagrelor and Cosyntropin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 8,499 Ticagrelor users. Check the latest studies of Ticagrelor.

What is Cosyntropin?

Cosyntropin has active ingredients of cosyntropin. eHealthMe is studying from 222 Cosyntropin users. Check the latest studies of Cosyntropin.



On Jul, 04, 2026

14 people who take Ticagrelor and Cosyntropin together, and have interactions are studied.

Ticagrelor and Cosyntropin drug interactions.

What are the common drug interactions of Ticagrelor and Cosyntropin, by gender? *:

female:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  2. Intussusception
  3. Pyelonephritis (inflammation of kidney caused by bacteria)
  4. Tetany (involuntary contraction of muscles)
  5. Blood creatine phosphokinase increased
  6. Chest pain
  7. Circulatory collapse
  8. Cystitis (inflammation of the wall of the bladder)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Blood creatinine increased

male:

n/a

What are the common drug interactions of Ticagrelor and Cosyntropin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  2. Blood creatinine increased
  3. Tetany (involuntary contraction of muscles)
  4. Blood creatine phosphokinase increased
  5. Chest pain
  6. Circulatory collapse
  7. Cystitis (inflammation of the wall of the bladder)
  8. Death
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Indigestion: 14 people, 100.00%
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 14 people, 100.00%
  3. Cough: 14 people, 100.00%
  4. Depression: 14 people, 100.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 100.00%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 14 people, 100.00%
  7. High Blood Pressure: 14 people, 100.00%
  8. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 14 people, 100.00%
  9. Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 14 people, 100.00%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 14 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ticagrelor and Cosyntropin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ticagrelor and Cosyntropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ticagrelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cosyntropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ticagrelor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cosyntropin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ticagrelor and cosyntropin (the active ingredients of Ticagrelor and Cosyntropin, respectively), and Ticagrelor and Cosyntropin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: